GAMC
VERA icon

Garner Asset Management Corp’s Vera Therapeutics VERA Stock Holding History

Garner Asset Management Corp’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$20.3K – 384
2025
Q4 		$20.3K Buy
+400
New +$14.2K 0.01% 290

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Garner Asset Management Corp's VERA Position: Q1 2026 in Review

Garner Asset Management Corp sold out of Vera Therapeutics (VERA) in Q1 2026, closing a stake of 400 shares — an estimated $20.3K sold.

Garner Asset Management Corp first reported a position in VERA in Q4 2025 and held it in 1 quarter. The position peaked at $20.3K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Garner Asset Management Corp reported no remaining Vera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Garner Asset Management Corp sold 400 Vera Therapeutics shares in Q1 2026, an estimated $20.3K.
  • Garner Asset Management Corp first reported a position in Vera Therapeutics in Q4 2025 and held it in 1 quarter.
  • Garner Asset Management Corp's Vera Therapeutics position peaked at $20.3K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Garner Asset Management Corp's 13F filing for Q1 2026, filed 29 Apr 2026.